From: Thoracic surgery in the COVID-19 era: an Italian university hospital experience
Non-pandemic group | Pandemic group | p-value | |
---|---|---|---|
Patients (N) | 352 | 294 | 0.0013 |
Age (yrs) | 67.3 ± 13 | 65.3 ± 13 | 0.20 |
Sex (F/M) | 100/148 | 62/101 | 0.68 |
Tumor size (mm) | 19.5 ± 13 | 28.2 ± 21 | 0.0001 |
T3-T4/T1-2 (N) | 16/97 | 30/56 | 0.0001 |
Waiting time (days) | 12.2 ± 5.3 | 20.2 ± 4.0 | 0.0001 |
Lost before treatment (N) | 8 | 15 | 0.01 |
Operative mortality (N) | 2 | 2 | 0.65 |
Operative morbidity (N) | 14 | 8 | 0.82 |
Hospital Stay (days) | 6.02 ± 5.0 | 5.25 ± 4.8 | 0.0001 |